Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?

Sofia España FernandezChen SunCarme Solé-BlanchAram BoadaAnna Martínez-CardúsJosé Luis Manzano

Published in: Pharmaceutics (2023)

It is possible to resume or rechallenge, but each patient should be evaluated by a multidisciplinary team for close monitoring and assessment of the risk/benefit ratio before initiating treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
palliative care
oxidative stress
quality improvement
peritoneal dialysis
clinical evaluation